Pancreatic cancer risk linked to weak sunlight

April 30, 2015, University of California - San Diego
Maps depict global incidence rates of pancreatic cancer (per 100,000) and ultraviolet B radiation (watts per square meter). Credit: UC San Diego School of Medicine

Writing in the April 30 online issue of the Journal of Steroid Biochemistry and Molecular Biology, researchers at University of California San Diego School of Medicine report pancreatic cancer rates are highest in countries with the least amount of sunlight. Low sunlight levels were due to a combination of heavy cloud cover and high latitude.

"If you're living at a high latitude or in a place with a lot of heavy cloud cover, you can't make vitamin D most of the year, which results in a higher-than-normal risk of getting pancreatic cancer," said first author Cedric F. Garland, DrPH, adjunct professor in the Department of Family Medicine and Public Health and member of UC San Diego Moores Cancer Center.

"People who live in sunny countries near the equator have only one-sixth of the age-adjusted incidence rate of pancreatic cancer as those who live far from it. The importance of sunlight deficiency strongly suggests - but does not prove - that vitamin D deficiency may contribute to risk of pancreatic cancer."

Limited foods naturally contain vitamin D. Fatty fish, such as salmon and tuna, are good sources; beef liver, cheese and egg yolks provide small amounts. Vitamin D is often added as a fortifying nutrient to milk, cereals and juices, but experts say most people also require additional vitamin D to be produce by the body when skin is directly exposed to sunlight. Specifically, ultraviolet B radiation. Skin exposed to sunshine indoors through a window will not produce vitamin D. Cloudy skies, shade and dark-colored skin also reduce vitamin D production.

The UC San Diego team, led by Garland and Edward D. Gorham, PhD, associate professor, had previously shown that sufficient levels of a metabolite of vitamin D in the serum, known as 25-hydroxyvitamin D was associated with substantially lower risk of breast and colorectal cancer. The current paper is the first to implicate vitamin D deficiency with pancreatic cancer.

Researchers studied data from 107 countries, taking into account international differences and possible confounders, such as alcohol consumption, obesity and smoking. "While these other factors also contribute to risk, the strong inverse association with cloud-cover adjusted sunlight persisted even after they were accounted for," said Garland.

UC San Diego researchers had previously identified an association of high latitude with a higher risk of pancreatic cancer. Garland said the new study advances that finding by showing that an estimate of solar ultraviolet B that has been adjusted for heavy produces an even stronger prediction of risk of .

Pancreatic cancer is the 12th most common cancer in the world, according to World Cancer Research Fund International, with 338,000 new cases diagnosed annually. Incidence rates are highest in North America and Europe; lowest in Africa and Asia. It is the seventh most common cause of death from cancer.

Explore further: Vitamin D increases breast cancer patient survival

Related Stories

Vitamin D increases breast cancer patient survival

March 6, 2014
Breast cancer patients with high levels of vitamin D in their blood are twice as likely to survive the disease as women with low levels of this nutrient, report University of California, San Diego School of Medicine researchers ...

Low vitamin D levels linked to high risk of premenopausal breast cancer

January 24, 2013
A prospective study led by researchers from the University of California, San Diego School of Medicine has found that low serum vitamin D levels in the months preceding diagnosis may predict a high risk of premenopausal breast ...

Lower vitamin D level in blood linked to higher premature death rate

June 12, 2014
Researchers at the University of California, San Diego School of Medicine have found that persons with lower blood levels of vitamin D were twice as likely to die prematurely as people with higher blood levels of vitamin ...

Researchers reveal how pancreatic cancer cells sidestep chemotherapy

January 30, 2015
Pancreatic cancer is one of the deadliest forms of the disease. The American Cancer Society's most recent estimates for 2014 show that over 46,000 people will be diagnosed with pancreatic cancer and more than 39,000 will ...

Recommended for you

A small, daily dose of Viagra may reduce colorectal cancer risk

March 19, 2018
A small, daily dose of Viagra significantly reduces colorectal cancer risk in an animal model that is genetically predetermined to have the third leading cause of cancer death, scientists report.

Cancer comes back all jacked up on stem cells

March 19, 2018
After a biopsy or surgery, doctors often get a molecular snapshot of a patient's tumor. This snapshot is important - knowing the genetics that cause a cancer can help match a patient with a genetically-targeted treatment. ...

Researchers create a drug to extend the lives of men with prostate cancer

March 16, 2018
Fifteen years ago, Michael Jung was already an eminent scientist when his wife asked him a question that would change his career, and extend the lives of many men with a particularly lethal form of prostate cancer.

Machine-learning algorithm used to identify specific types of brain tumors

March 15, 2018
An international team of researchers has used methylation fingerprinting data as input to a machine-learning algorithm to identify different types of brain tumors. In their paper published in the journal Nature, the team ...

Higher doses of radiation don't improve survival in prostate cancer

March 15, 2018
A new study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment. The analysis, which included 104 radiation therapy oncology ...

Joint supplement speeds melanoma cell growth

March 15, 2018
Chondroitin sulfate, a dietary supplement taken to strengthen joints, can speed the growth of a type of melanoma, according to experiments conducted in cell culture and mouse models.


Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Apr 30, 2015
This is interesting, but I wonder if the researchers adjusted risk based on the variable of access to diagnostic services. The countries with a low incidence of pancreatic cancers are primarily third-world countries. Pancreatic cancer strikes hard and kills fast. In many poor countries it most likely is never diagnosed because to diagnose it requires at the minimum a CT scan, although technically a tissue biopsy is required to officially make the diagnosis. Many poor people get sick, lose weight, and die without the "benefit" of CT scans and chemotherapy.
not rated yet May 06, 2015
Pancreatic Cancer, UC San Diego Researchers and Father of Oncology. Because cancer researchers scared they will lose money-2015-2050 due to new anticancer iron-deficiency methods, pancreatic cancer can be hard to treat. Scientific iron/cancer information-1905-2015 is largely distorted. Pancreatic cancer is fundamentally a disease caused by cellular iron overload, the Father of Oncology says. Primary tumors always develop at body sites of excessive iron deposits. Such deposits can be inherited or acquired. Cancer is the result of bad luck. UC San Diego researchers can beat pancreatic cancer. Direct intratumoral injections of iron-deficiency agents (ceramic needles) can successfully eliminate inoperable tumors and metastases. Personalized clinical iron-deficiency methods can successfully neutralize micrometastases and HIV. Cancer can be beaten http://www.medica...s/184826 ; http://medicalxpr...ght.html ; Shapoval

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.